The Impact of China’s Human Genetic Resources Regime on Biopharma MNC’s, China Law & Practice
Friday, May 14, 2021
Morgan Lewis partner Todd Liao was quoted in a China Law & Practice article about China’s human genetic resources (HDR) regime. Todd said that some have found the requirements “overreaching and onerous.”